The Expected and the Unexpected Difficult Airway - PowerPoint PPT Presentation

1 / 25
About This Presentation
Title:

The Expected and the Unexpected Difficult Airway

Description:

– PowerPoint PPT presentation

Number of Views:277
Avg rating:3.0/5.0
Slides: 26
Provided by: pain1
Category:

less

Transcript and Presenter's Notes

Title: The Expected and the Unexpected Difficult Airway


1
The Expected and the Unexpected Difficult Airway
  • Lei Wang, MD

2
Case 1
  • J.N is a 12 yo boy S/F dental restoration
  • PMH Congenital-Hunters syndrome
  • 1. Partial airway obstruction occ. sleep apnea.
  • 2. History of heart murmur with normal cardiac
    function
  • 3. Extremity weakness partial contracture
    unable to sit up.
  • 4. Severe developmentally delayed.

3
Hunters Syndrome
4
Case 1 (cont)
  • PSH MRI in 1997 under GA with fiber optic
    intubation. Pt was intubated for three days
    postop for upper airway edema.
  • Allergies NKDA
  • Meds Benadryl PRN

5
Physical Exam
  • BP 95/56 P 74 RR 20 SpO2 99 28kg
  • Airway macroglossia with protruding tongue.
    Patient has copious drooling.
  • Neck short neck. Unable to exam ROM.
  • Pulm coarse upper airway noises.
  • Cardiac RRR
  • Extremities partial contracture UE and LE
  • Neuro developmental delay.

6
Planned Anesthetic Management
  • A. Peripheral IV placed preop.
  • B. Anesthetized nasal fiberoptic intubation with
    spontaneous ventilation.

7
Anesthetic Management-cont.
  • A. Peripheral IV placed preop.
  • B. Anesthetized nasal fiberoptic intubation with
    spontaneous ventilation.
  • C. DL reviewed grade IV view.
  • D. Patient stable during procedure.
  • E. Patient extubated awake after placing a tube
    changer in the trachea.

8
Anesthetic Management-cont.
  • F. Patient was able to maintain patent upper
    airway.
  • G. Patient discharged to home on postop day1.

9
Hunters syndrome
  • AKA mucopolysaccharidosis II
  • Etiology X-linked hereditary disorder of
    lysosomal enzyme, iduronate sulfatase, resulting
    accumulation of incompletely metabolized
    mucopolysaccharide, dermatan sulfate and heparan
    sulfate, in tissues through out the body.

10
Hunters syndrome
  • Incidence 1/30,000 for mucopolysaccharidosis in
    U.S.
  • Natural history gradual decline in growth rate
    from 2 to 6 years of age.
  • Deafness at 2 to 3 years of age.
  • Death common prior to 15 years due to cardiac and
    pulmonary failure.

11
Hunters syndrome
  • Growth deficiency onset 2 to 6 years of age.
  • Neurologic mental and neurologic deterioration
    at 2 to 5 years partial contracture joints occ.
    Hydrocephalus and seizure disorder.
  • Craniofacial Macrocephaly coarsening of facial
    features.

12
Hunters syndrome
  • Airway macroglossia small mouth opening
    relative micrognathia airway obstruction
    possible altanto-axial subluxation.
  • Cardiovascular possible cardiomyopathy valvular
    disease coronary occlusion, and CHF (older
    adolescent patients)

13
Hunters syndrome
  • Anesthetic considerations
  • 20 perioperative mortality
  • Difficult airway 25 difficult intubation
  • Cardiac instability
  • Difficult IV placement
  • Difficult padding and positioning

14
Case 2
  • J.L. is a 4 year-old boy S/F palatoplasty
  • PMH Trisomy 22
  • Highly arched palate
  • Polycystic kidneys
  • Left ear malformation
  • Developmental delay, but catching up
  • Denies cardiac or pulmonary disease

15
Case 2, cont.
  • PSH none
  • Allergies NKDA
  • Meds none
  • Labs Hct 39.6 K 4.1 BUN 8 Cr 0.4

16
Case 2 Physical Exam
  • Vitals BP 102/61 P 88 RR 25 SpO2 97 Ht
    99cm Wt 13 kg
  • Airway not evaluated
  • HEENT microcephaly mild micrognathia high
    arched palate left ear malformation
  • Neck FROM
  • CV RRR
  • Lungs CTA
  • Neuro normal mental development

17
Anesthetic Management
  • Inhalation induction- smooth
  • IV placed Vecuronium 0.1 mg/kg administered
  • Easy mask ventilation

18
Anesthetic Management
  • Inhalation induction- smooth
  • IV placed Vecuronium 0.1 mg/kg administered
  • Easy mask ventilation
  • DLx6 with different blades grade IV view

19
Anesthetic Management
  • Inhalation induction- smooth
  • IV placed Vecuronium 0.1 mg/kg administered
  • Easy mask ventilation
  • DLx6 with different blades grade IV view
  • Fiberoptic via oral airway unsuccessful due to
    excessive soft tissue and bleeding

20
Anesthetic Management
  • Inhalation induction- smooth
  • IV placed Vecuronium 0.1 mg/kg administered
  • Easy mask ventilation
  • DLx6 with different blades grade IV view
  • Fiberoptic via oral airway unsuccessful due to
    excessive soft tissue and bleeding
  • Light wand unsuccessful

21
Anesthetic Management
  • LMA 2 placed. Trachea intubated under fiberoptic
    guidance using LMA as a conduit
  • Patient stable during surgery
  • Patient extubated awake at the end of case
  • Patient D/C home on postop day 2

22
Trisomy 22
  • A very rare congenital chromosomal disorder. Most
    patient die a few days after birth
  • Anomalies includes growth retardation,
    psychomotor delay, microcephaly, micrognathia,
    broad nasal bridge, low-set malformed ears,
    highly arched palate, hypertelorism, congenital
    heart disease.

23
ASA difficult airway algorithm
24
ASA difficult airway algorithm
25
ASA difficult airway algorithm
Write a Comment
User Comments (0)
About PowerShow.com